Literature DB >> 2011

Review of drug treatment for Down's syndrome persons.

J B Share.   

Abstract

A review of drug treatment for Down's syndrome individuals was presented. Drugs used to modify behavior, as well as drugs used with the goal of affecting cognitive processes, were discussed. Some observations were offered as to the effectiveness of past and current drugs on Down's syndrome and some methodological problems relating to drug studies presented. There have not been any drugs that have demonstrated remarkable improvement in the status of Down's syndrome individuals that have been widely accepted as effective.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 2011

Source DB:  PubMed          Journal:  Am J Ment Defic        ISSN: 0002-9351


  6 in total

1.  Withdrawal of chronic chlorpromazine medication: an experimental analysis.

Authors:  D Marholin; P E Touchette; R M Stewart
Journal:  J Appl Behav Anal       Date:  1979

Review 2.  The Role of Stem Cells in the Treatment of Cerebral Palsy: a Review.

Authors:  Anahita Kiasatdolatabadi; Nasrin Lotfibakhshaiesh; Meysam Yazdankhah; Somayeh Ebrahimi-Barough; Mina Jafarabadi; Arman Ai; Esmaeil Sadroddiny; Jafar Ai
Journal:  Mol Neurobiol       Date:  2016-08-13       Impact factor: 5.590

3.  Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.

Authors:  P T Dick
Journal:  CMAJ       Date:  1996-02-15       Impact factor: 8.262

4.  Pyroptosis in sepsis: Comprehensive analysis of research hotspots and core genes in 2022.

Authors:  Demeng Xia; Sheng Wang; Renqi Yao; Yuexue Han; Liyu Zheng; Pengyi He; Ying Liu; Lu Yang
Journal:  Front Mol Biosci       Date:  2022-08-11

5.  Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients.

Authors:  Mark Stettner; Christoph Kleinschnitz; Michael Fleischer; Fabian Szepanowski; Muriel Tovar; Klaas Herchert; Hannah Dinse; Adam Schweda; Anne K Mausberg; Dagny Holle-Lee; Martin Köhrmann; Julia Stögbauer; Daniel Jokisch; Martha Jokisch; Cornelius Deuschl; Eva-Maria Skoda; Martin Teufel
Journal:  Neurol Ther       Date:  2022-08-26

6.  Clopidogrel Protects Endothelium by Hindering TNFα-Induced VCAM-1 Expression through CaMKKβ/AMPK/Nrf2 Pathway.

Authors:  Huabing Yang; Pengjun Zhao; Shiliu Tian
Journal:  J Diabetes Res       Date:  2015-12-28       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.